Koers Hypertension Diagnostics, Inc. Other OTC
Aandelen
HDII
US44914V1044
Geavanceerde medische apparatuur & technologie
Omzet 2017 | 3,68 mln. 3,41 mln. | Omzet 2018 | 3,79 mln. 3,51 mln. | Marktkapitalisatie | 92,08K 85,29K |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 | Nettowinst (verlies) 2018 | - 0 | EV/omzet 2017 | 1,15 x |
Nettoschuld 2017 | 4,13 mln. 3,83 mln. | Nettoschuld 2018 | 4,6 mln. 4,26 mln. | EV/omzet 2018 | 1,24 x |
K/w-verhouding 2017 |
-0,28
x | K/w-verhouding 2018 |
-0,54
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,91% | 204 mld. | |
+3,74% | 178 mld. | |
+28,89% | 154 mld. | |
+31,66% | 112 mld. | |
+1,75% | 64,16 mld. | |
+19,45% | 54,88 mld. | |
-3,44% | 46,69 mld. | |
-9,28% | 36,8 mld. | |
-0,10% | 35,26 mld. |